Edition:
United States

Magforce AG (MF6G.F)

MF6G.F on Frankfurt Stock Exchange

5.50EUR
7:11am EST
Change (% chg)

€-0.15 (-2.65%)
Prev Close
€5.65
Open
€5.55
Day's High
€5.55
Day's Low
€5.50
Volume
1,000
Avg. Vol
17,497
52-wk High
€8.14
52-wk Low
€4.46

Summary

Name Age Since Current Position

Norbert Neef

50 2011 Chairman of the Supervisory Board

Ben Lipps

78 2013 Chairman of the Management Board, Chief Executive Officer

Christian von Volkmann

46 2012 Member of the Management Board, Chief Financial Officer

Hoda Tawfik

62 2012 Member of the Management Board, Chief Medical Officer

Klemens Hallmann

2017 Member of the Supervisory Board

Wiebke Roesler

2014 Member of the Supervisory Board

Barbara von Frankenberg

2016 Vice President Communications & Investor Relations

Biographies

Name Description

Norbert Neef

Mr. Norbert Neef has been Chairman of the Supervisory Board of MagForce AG since October 25, 2011. He is a founder and partner of Neef Legal Attornies, specializing in legal services for private equity, venture capital, and mergers & acquisitions. Mr. Neef began his career at international law firms. Mr. Neef serves on the advisory boards of several private companies and was most recently Chairman of the Supervisory Board of Mood and Motion AG. He also taught corporate law at Cologne University of Applied Sciences for ten years and has recently continued his teaching activities at the Fresenius University of Applied Sciences.

Ben Lipps

Dr. Ben J. Lipps has been Chairman of the Management Board and Chief Executive Officer at Magforce AG since September 1, 2013. He became Chairman and Chief Executive Officer of the Management Board of Fresenius Medical Care in May 1999. In December 2012 he stepped down as Chairman of the Management Board and Chief Executive Officer. He was also Chief Executive Officer of Fresenius Medical Care North America until February 2004. He was President, Chief Executive Officer, Chief Operating Officer and a director of Fresenius USA from October 1989 through February 2004, and served in various capacities with Fresenius USA’s predecessor from 1985 through 1989. Before joining the Fresenius Group in 1985, Dr. Lipps held several research management positions in various companies, among them with DOW Chemical. He earned his master’s and doctoral degrees at the Massachusetts Institute of Technology in chemical engineering.

Christian von Volkmann

Mr. Christian von Volkmann has been Member of the Management Board and Chief Financial Officer at MagForce AG since October 1, 2012. Prior to that, he served as Acting Chief Financial Officer of the Company from May 3, 2012. He has more than 15 years of international experience in corporate finance/capital market transactions, group structuring and Mergers & Acquisitions. At Jerini AG (Berlin, Germany), which he joined in 2004, he served as Director of Finance. He also founded and headed Berlin-based CMaP Financial Consulting. Prior to his position at Jerini, Mr. von Volkmann worked at the auditing company Ernst & Young for six years. He holds a diploma of the Julius-Maximilians-Universitaet Wuerzburg, where he studied business administration with a focus on taxation, audit and consultancy as well as bank administration and Corporate Finance. He is also a licensed Certified Public Accountant in the United States.

Hoda Tawfik

Prof. Dr. Hoda Tawfik has been Member of the Management Board and Chief Medical Officer of MagForce AG since October 1, 2012. Prior to that, she served as Vice President - Research & Development and Medical Affairs at the Company from May 2011. She has over 20 years of experience in clinical development and medical affairs in both CRO (contract research organizations) and the pharma/biotech industry. Before joining MagForce, she worked at Medigene AG where she was Head of Clinical Operations and Medical Affairs for nine years. She completed her pharmacy studies at the University of Cairo, and subsequently obtained her Ph.D. in pharmacology and toxicology at the University of Duesseldorf. She then worked in pharmacological research at the universities of Cairo, Heidelberg, and Munich. In addition she held the post of Professor of Pharmacology at the University of Cairo.

Klemens Hallmann

Mr. Klemens Hallmann has been Member of the Supervisory Board at MagForce AG since 2017. He He is the founder of HALLMANN Group, one of the largest private real estate development companies in Austria. Mr. Hallmann is core shareholder and Member of the Supervisory Board of C-Quadrat Investment AG. Moreover, he is Member of the Supervisory Board of JDC Group AG, a listed German financial services company, plus he is a core shareholder and member of the supervisory board of the Austrian SÜBA Beteiligungs Aktiengesellschaft. Besides his business life, he is engaged in numerous social projects, for instance, with the African Aids Federation (in cooperation with the UNODC); Light into Darkness (Licht ins Dunkel); and the Don Bosco Youth Foundation, where he is a member of the advisory board. Furthermore, he is Vice President of the Austrian-United Arab Emirates Society and supports many smaller organizations.

Wiebke Roesler

Dr. Wiebke Roesler has been Member of the Supervisory Board of MagForce AG since August 19, 2014. She worked as specialist at Medizinische Hochschule Hannover, Center for Internal Medicine, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. She has many years of experience as an internist specializing in hematology and oncology. She participated as sub investigator in clinical studies concerning Hodgkin-Lymphoma, Non-Hodgkin-Lymphoma, acute and chronic leukemia.

Barbara von Frankenberg

Ms. Barbara von Frankenberg has been Vice President Communications & Investor Relations of MagForce AG since March 16, 2016. Prior to joining MagForce, she spent 16 years as Investor Relations Manager, holding senior roles with publicly listed high-tech companies.